Rules-Based Medicine Raises $25 Million

Rules-Based Medicine Inc., an Austin, Texas-based multiplexed biomarker testing laboratory, has raised $25 million in Series A funding. Equity Group Investments led the round, and was joined by Cross Creek Capital and Stephens Capital Partners. As part of the deal, EGI managing director Matt Zell has joined the Rules-Based Medicine board of directors.